Status:
COMPLETED
Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function"
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Danish Heart Foundation
Conditions:
Heart Failure
Diabetes
Eligibility:
All Genders
30-85 years
Phase:
PHASE2
Brief Summary
The investigators wish to investigate the the short term effect of low circulating free fatty acids in congestive heart failure patients with type 2 diabetes. Hypothesis: Low levels of circulating fr...
Eligibility Criteria
Inclusion
- ejection fraction at or lower than 45%
- type 2 diabetes
Exclusion
- known s-creatinine \>220mM
- known S-alanine aminotransferase \>3 times normal upper limit
- other disabilitating conditions
- pregnancy
- insulin treatment
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01192373
Start Date
September 1 2010
End Date
March 1 2012
Last Update
January 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of cardiology, Aarhus University hospital Skejby,
Aarhus, Region Midjylland, Denmark, 8200